Insulet (Germany) Performance

GOV Stock  EUR 251.20  0.10  0.04%   
On a scale of 0 to 100, Insulet holds a performance score of 22. The company retains a Market Volatility (i.e., Beta) of 0.0572, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Insulet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Insulet is expected to be smaller as well. Please check Insulet's sortino ratio, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance , to make a quick decision on whether Insulet's current trending patterns will revert.

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Insulet are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Insulet reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow806.4 M
  

Insulet Relative Risk vs. Return Landscape

If you would invest  18,155  in Insulet on September 2, 2024 and sell it today you would earn a total of  6,965  from holding Insulet or generate 38.36% return on investment over 90 days. Insulet is currently producing 0.5083% returns and takes up 1.7841% volatility of returns over 90 trading days. Put another way, 15% of traded stocks are less volatile than Insulet, and 90% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Insulet is expected to generate 2.4 times more return on investment than the market. However, the company is 2.4 times more volatile than its market benchmark. It trades about 0.28 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.2 per unit of risk.

Insulet Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Insulet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insulet, and traders can use it to determine the average amount a Insulet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.2849

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsGOV
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.78
  actual daily
15
85% of assets are more volatile

Expected Return

 0.51
  actual daily
10
90% of assets have higher returns

Risk-Adjusted Return

 0.28
  actual daily
22
78% of assets perform better
Based on monthly moving average Insulet is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insulet by adding it to a well-diversified portfolio.

Insulet Fundamentals Growth

Insulet Stock prices reflect investors' perceptions of the future prospects and financial health of Insulet, and Insulet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insulet Stock performance.

About Insulet Performance

By analyzing Insulet's fundamental ratios, stakeholders can gain valuable insights into Insulet's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Insulet has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Insulet has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts. INSULET CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1169 people.

Things to note about Insulet performance evaluation

Checking the ongoing alerts about Insulet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insulet help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Insulet has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Insulet has accumulated about 316.37 M in cash with (68.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.3.
Over 100.0% of the company shares are owned by institutional investors
Evaluating Insulet's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Insulet's stock performance include:
  • Analyzing Insulet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insulet's stock is overvalued or undervalued compared to its peers.
  • Examining Insulet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Insulet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insulet's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Insulet's stock. These opinions can provide insight into Insulet's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Insulet's stock performance is not an exact science, and many factors can impact Insulet's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Insulet Stock analysis

When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes